GLP-1S and GLP-2T are both lipidated incretin-receptor ligands used in receptor pharmacology research. The critical distinction is receptor selectivity: GLP-1S is a single-target GLP-1 receptor agonist, while GLP-2T is a dual GIP/GLP-1 receptor agonist.
| Property | GLP-1S | GLP-2T |
|---|---|---|
| Category | GLP-1 receptor agonist (single agonist) | GIP/GLP-1 dual receptor agonist (twincretin) |
| Mechanism of Action | Activates the GLP-1 receptor, a Gs-coupled GPCR, raising intracellular cAMP in receptor-expressing cell lines | Activates both GIP and GLP-1 receptors; used to study dual incretin receptor signaling and cAMP responses |
| Molecular Weight | ~4,113 Da | ~4,810 Da |
| Research Focus | GLP-1 receptor binding and signaling assays | Dual GIP/GLP-1 receptor signaling and biased-agonism assays |
| Receptor Target | GLP-1 receptor (selective) | GIP receptor (primary) + GLP-1 receptor (secondary) |
| Half-Life | ~7 days (albumin binding via C-18 fatty diacid) | ~5 days (C-20 fatty diacid moiety enables albumin binding) |
The fundamental difference between GLP-1S and GLP-2T lies in receptor pharmacology. GLP-1S is a selective GLP-1 receptor agonist. GLP-2T introduces a dual agonist mechanism targeting both GIP and GLP-1 receptors. Both peptides have extended half-lives through albumin-binding fatty acid modifications, which is relevant to assay design and stability studies.
GLP-1S is a selective GLP-1 receptor agonist with a ~7-day half-life, while GLP-2T is a dual GIP/GLP-1 receptor agonist with a ~5-day half-life. The key distinction is that GLP-2T activates two incretin receptors simultaneously, which makes the pair useful for comparing single-receptor and dual-receptor signaling in cell-based assays.
Disclaimer: All compounds referenced on this page are sold for research and laboratory use only. The comparisons presented are based on published scientific literature and are intended for educational and informational purposes. This content does not constitute medical advice. Researchers should consult primary literature and applicable regulations before designing study protocols.